Company intelligence / Profile preview

Altach Biomedical

Dublin, Ireland

Ownership: Private
Development stage: Other

Overview

Altach Biomedical is advancing a Type II collagen biomimetic scaffold through pre-clinical development to address articular cartilage injuries, aiming to promote innate cartilage regeneration as a superior alternative to conventional repair; US patent granted and scale-up for validation in advance of clinical use is underway. Clinical trial initiation is planned but has not yet started as of late 2024[1][2][3].

Therapeutic areas: Rheumatology
Modalities: BiomaterialDevice
Industry: Implantable Medical Devices

Partnerships

NLC Health Ventures

Beyond the preview

Go deeper on Altach Biomedical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Altach Biomedical.

Explore the full profile